# US 2015/0305930 A1 · Vacuum-assisted drug delivery device and method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0305930 A1
- Document ID: US20150305930A1
- Status: Published application
- Kind: A1
- Application number: 14/694,703
- Filed: 2015-04-23
- Published: 2015-10-29
- Earliest claimed: 2014-04-23
- Assignees: Seros Medical, LLC
- Applicants: Seros Medical, LLC
- Inventors: David Myung; Edward E. Manche; Donald J. Eaton; Anthony J. Abbate
- Web page: https://patentgrep.com/patent/US20150305930A1

## CPC

- A61F 9/0017: {implantable in, or in contact with, the eye, e.g. ocular inserts}
- A61M 1/80: {Suction pumps (A61M1/64, A61M1/71, A61M60/00 take precedence)}
- A61M 1/802: {by vacuum created above a liquid flowing from a closed container}
- A61M 35/003: {Portable hand-held applicators having means for dispensing or spreading integral media (hand-held massage devices with liquid delivery A61H7/003)}
- A61M 37/00: Other apparatus for introducing media into the body (for reproduction or fertilisation A61B17/425; apparatus for iontophoresis or cataphoresis A61N1/30); Percutany, i.e. introducing medicines into the body by diffusion through the skin (salt baths A61H33/04)
- A61M 1/00: Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems (catheters A61M25/00; tube connectors, tube couplings, valves or branch units specially adapted for medical use A61M39/00; devices for taking samples of blood A61B5/15; filters implantable into blood vessels A61F2/01)
- A61M 1/75: {Intermittent or pulsating suction (A61M1/63, A61M1/772 take precedence)}
- A61M 2037/0007: {having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents}
- A61M 2210/0612: Eyes
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

This invention relates to a device and method for the vacuum-assisted delivery of drugs through an intact surface membrane of an organ.

## Claims

### Claim 1

A drug delivery device, comprising:
a vacuum source; and
a drug reservoir operatively coupled to the vacuum source; wherein:
the drug reservoir comprises a surface that is conformed to or is conformable with a target surface membrane of an organ to form an air-tight contact between the drug reservoir surface and the target surface membrane and wherein
a fluid within the drug reservoir is in fluid communication with the target surface membrane when the drug reservoir surface is in contact with the target surface membrane.

### Claim 2 (depends on 1)

The drug delivery device of claim 1, wherein the vacuum source is selected from the group consisting of a manual pump, an electric pump and a digitally programmable pump.

### Claim 3 (depends on 2)

The drug delivery device of claim 2, wherein the vacuum source is operatively coupled to the drug reservoir via a rigid or flexible tube.

### Claim 4 (depends on 1)

The drug delivery device of claim 1, further comprising a fluid injection port.

### Claim 5 (depends on 4)

The drug delivery device of claim 4, wherein the fluid injection port is coupled to the drug reservoir or to a rigid or flexible tube that operatively couples the drug reservoir to the vacuum source.

### Claim 6 (depends on 1)

The drug delivery system of claim 1, wherein the fluid in the drug reservoir is in fluid communication with the target surface membrane via a plurality of pores in the drug reservoir surface that is in contact with the target surface membrane.

### Claim 7 (depends on 1)

The drug delivery device of claim 1, wherein the fluid in the drug reservoir is in fluid communication with the target surface membrane via an interconnected or open cell foam material or a porous material, either of which comprises a plurality of channels that extend from a surface of the foam or nanoporous material that is in contact with the fluid in the drug reservoir to the surface of the foam or porous material that is in contact with the target surface membrane.

### Claim 8 (depends on 1)

The drug delivery device of claim 1, further comprising a proximal flow inhibitor to prevent or reduce the fluid in the drug reservoir from being withdrawn from the drug reservoir when a vacuum is being created by the vacuum source.

### Claim 9 (depends on 6)

The drug delivery device of claim 6, wherein the plurality of pores have a diameter of from about 0.001 mm to about 10 mm.

### Claim 10 (depends on 6)

The drug delivery device of claim 6, wherein the plurality of pores number from 100 to about 1,000,000 pores.

### Claim 11 (depends on 1)

The drug delivery device of claim 1, wherein the vacuum source is capable of creating a vacuum down to about 1 to 300 torr.

### Claim 12 (depends on 1)

The drug delivery device of claim 1, further comprising a controller configured to provide pulsing of the vacuum source to create and release a vacuum in the drug reservoir when the drug reservoir surface is conformed to and in contact with the target surface membrane.

### Claim 13 (depends on 12)

The drug delivery device of claim 12, wherein the controller is configured to pulse the vacuum source between about 1 torr to about 760 torr.

### Claim 14 (depends on 13)

The drug delivery device of claim 13, wherein the controller is configured to pulse the vacuum source at a cyclic rate from about 5 seconds to about 20 seconds.

### Claim 15

A method for delivering a drug into an eye of a patient non-invasively for treating a disease or condition in the patient in need thereof, comprising:
placing a surface of a drug reservoir in contact with an epithelial or conjunctival surface of the eye to which the surface of the drug reservoir has been conformed such that an air-tight contact between the drug reservoir surface and the epithelial or conjunctival surface is formed and such that a fluid in the drug reservoir is placed in fluid communication with the epithelial or conjunctival surface; and
creating a vacuum within the drug reservoir to effect diffusion of the fluid in the drug reservoir through the epithelial or conjunctival surface and into the subsurface of the eye.

### Claim 16 (depends on 15)

The method of claim 15, wherein the surface of the eye is the epithelial surface.

### Claim 17 (depends on 16)

The method of claim 16, where the fluid comprises a substance that is capable of catalyzing the cross-linking of macromolecules in the eye.

### Claim 18 (depends on 15)

The method of claim 15, wherein the fluid comprises an anti-microbial, an anti-inflammatory, an analgesic, antiseptic, or an anti-VEGF drug.

### Claim 19 (depends on 15)

The method of claim 15, wherein the delivery of a drug is for the treatment of uveitis, keratoconus, glaucoma, dry eye, diabetic macular edema, age-related macular degeneration, corneal infection or cytomegalovirus retinitis.

### Claim 20 (depends on 15)

The method of claim 15, wherein the vacuum is a pressure between 1 and 100 torr.

### Claim 21

A device for vacuum-assisted delivery of drug to a target surface membrane of a patient in need of treatment of a disease or condition, comprising:
a device body comprising a proximal end and a distal end having fluid communication between the proximal and distal end to allow for creation of a vacuum within the device body;
a diffusive membrane at or near the proximal end for contacting with the target surface membrane through which a fluid comprising drug for treating the disease or condition permeates from the device to the target surface membrane when a vacuum is applied to the device,
wherein the diffusive membrane provides support to the target surface membrane during application of the vacuum which reduces or prevents damage to the target surface membrane during application of the vacuum,
wherein the diffusive membrane is porous to allow permeation of the fluid from the device to the target surface membrane;
a proximal flow inhibitor mechanism that reduces or prevents proximal flow of the fluid away from the diffusive membrane during application of the vacuum; and
a fluid distributer proximal to the diffusive membrane having a distal surface which provides for uniform distribution and delivery of fluid over an area of the diffusive membrane.
